Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 19Neoplasms 7Breast Neoplasms 5Pancreatic Neoplasms 4Hematologic Neoplasms 4Ovarian Neoplasms 3Neoplasm Metastasis 3Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Sarcoma 2Prostatic Neoplasms 2Neoplasms by Site 2Neoplasms by Histologic Type 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Gastrointestinal Neoplasms 2Erdheim-Chester Disease 2Colorectal Neoplasms 2Xanthogranuloma, Juvenile 1Thyroid Neoplasms 1Thrombocytosis 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Clear Cell 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Gemcitabine 2selinexor 1ponatinib 1neratinib 1folfirinox 1contrast agent BR1 1cobimetinib 1ceritinib 1brigatinib 1abemaciclib 1Urination 1S 1 (combination) 1Radiotherapy 1Radiosurgery 1Practice Guidelines as Topic 1Pancreaticoduodenectomy 1Paclitaxel 1Oxaliplatin 1Long Interspersed Nucleotide Elements 1Laparoscopy 1Irinotecan 1Immunotherapy, Adoptive 1Floxuridine 1Etoposide 1Endosonography 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Drug Therapy 1Doxorubicin 1Colchicine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Pancreatic Ductal × cobimetinib × Clear all
NCT06813079 2025-02-18

Using Tumor Models to Determine Treatments

University Health Network, Toronto

Phase 2 Not yet recruiting
25 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡